Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,253Revenue $M297Net Margin (%)-88.8Z-Score1.5
Enterprise Value $M3,379EPS $-3.2Operating Margin %-2.9F-Score4
P/E(ttm))0Cash Flow Per Share $-1.7Pre-tax Margin (%)-90.8Higher ROA y-yN
Price/Book6.110-y EBITDA Growth Rate %0Quick Ratio1.4Cash flow > EarningsY
Price/Sales7.45-y EBITDA Growth Rate %0Current Ratio1.5Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-42.0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-159.2Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M125ROI % (ttm)-72.1Gross Margin Increase y-yN

Gurus Latest Trades with HZNP

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
HZNPJoel Greenblatt 2014-12-31 Add$10.61 - $13.47
$ 26.0052%Add 33.48%107,898
HZNPJoel Greenblatt 2014-09-30 Add$8.265 - $16.27
$ 26.0056%Add 39.93%80,834
HZNPJoel Greenblatt 2014-06-30 Buy 0.01%$12.02 - $16.32
$ 26.0045%New holding57,769
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

HZNP is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!

HZNP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Himawan JeffDirector 2015-03-13Sell554,564$22.4411.36view
Himawan JeffDirector 2015-03-10Sell1,614,827$21.8514.37view
Himawan JeffDirector 2014-11-19Sell3,450,000$12.05107.39view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2014-11-19Sell24,999$12.05107.39view
Walbert Timothy PChairman, President and CEO 2014-11-19Sell150,000$12.05107.39view
Nohria VirinderDirector 2014-11-13Sell2,000,000$11.54116.55view
VENKATARAMAN BALAJIFormer 10% Owner 2014-11-13Sell6,086,957$11.54116.55view
Nohria VirinderDirector 2014-11-13Sell1,739,130$11.54116.55view
Kelly David GeorgeEVP & Corporate Secretary 2014-11-06Sell0$0116.55view
DE VAERE ROBERT JEVP & CFO 2014-09-30Sell51,942$12.28103.5view

Press Releases about HZNP :

    Quarterly/Annual Reports about HZNP:

    News about HZNP:

    Articles On GuruFocus.com
    Biotech Effectiveness: Horizon Pharma, Zafgen, XOMA Corp Mar 09 2015 
    Horizon Pharma plc to Host Fourth Quarter 2014 Conference Call and Webcast on February 27, 2015 Jan 28 2015 
    Horizon Pharma plc Provides Business Update Jan 12 2015 
    Horizon Pharma plc Files Patent Infringement Lawsuit Against Watson Laboratories, Inc. for Filing an Dec 24 2014 
    Horizon Pharma plc to Present at the 26th Annual Piper Jaffray Healthcare Conference Nov 24 2014 
    Horizon Pharma plc Announces Pricing of Secondary Offering of Ordinary Shares by Selling Shareholder Nov 14 2014 
    Horizon Pharma plc Announces Proposed Secondary Offering of Ordinary Shares by Selling Shareholders Nov 13 2014 
    Horizon Pharma plc Announces Favorable Markman Ruling in RAYOS(R) (prednisone) Delayed-Release Table Nov 12 2014 
    Horizon Pharma plc Appoints John J. Kody as Executive Vice President and Chief Commercial Officer Nov 06 2014 
    Horizon Pharma plc Announces DUEXIS(R) Selected as Winner of Chicago Innovation Award Oct 31 2014 

    More From Other Websites
    Patent cliff continues to drive mergers in drug industry Mar 30 2015
    US STOCKS-Wall St bounces back from recent losses; deals help Mar 30 2015
    US STOCKS-Wall St bounces back from recent losses; deals help Mar 30 2015
    Energy Sector Leads Stock Markets Higher as Rally Rolls On Mar 30 2015
    U.S. Stocks Surge on Central Banks' Support for Growth Mar 30 2015
    Hedge Fund Deerfield Management Nets Two Scores In Pharma Merger Monday Mar 30 2015
    Stocks rally as the Dow jumps more than 250 Mar 30 2015
    Busiest Day for Health-Care Deals Is Set to Spawn More: Real M&A Mar 30 2015
    GLOBAL MARKETS-Stocks gain on merger activity, dollar rises Mar 30 2015
    Horizon Pharma buying Hyperion for about $1.1 billion Mar 30 2015
    Horizon Pharma buying Hyperion for about $1.1 billion Mar 30 2015
    Notable option activity in equities Mar 30 2015
    A Big Day for Healthcare M&A Mar 30 2015
    Pharma dealmaking helps lift US stocks Mar 30 2015
    US STOCKS-Wall St higher as biotechs rally on M&A deals Mar 30 2015
    Teva to Buy Auspex for $3.5 Billion to Boost Neurology Arm Mar 30 2015
    HYPERION THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of... Mar 30 2015
    Stocks Roll Out Healthy Start; JPMorgan, Apple, Gentherm Climb Mar 30 2015
    US stocks jump on UnitedHealth deal Mar 30 2015
    Ireland's Horizon to buy U.S. drugmaker Hyperion for $1.1 billion Mar 30 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial